American Journal Of Social Sciences And Humanity Research
162
https://theusajournals.com/index.php/ajsshr
VOLUME
Vol.05 Issue05 2025
PAGE NO.
162-167
10.37547/ajsshr/Volume05Issue05-40
The Influence Of TGF-
Β1
Blood Level Regulation on
Regenerative Processes in The Human Body
Golib Tolmasovich Kurbanov
Ph.D., Samarkand State Medical University, Uzbekistan
Received:
28 March 2025;
Accepted:
24 April 2025;
Published:
26 May 2025
Abstract:
According to Charles Darwin’s firs
t rule of regeneration, the higher the level of biological organization
in a species, the lower its regenerative capacity. Regeneration is the biological process through which living
organisms restore worn-out or damaged structures, often synonymously referred to as reparation. From a
biological standpoint, regeneration is considered an adaptive mechanism. Virtually all diseases cause structural
damage to tissues and organs, while recovery depends on the organism’s ability to regenerate these structures.
This article explores the role of transforming growth factor beta 1 (TGF-
β1) in tissue regeneration, highlighting its
action through both dependent and independent signaling pathways.
Keywords:
Regeneration, transforming growth factor beta 1 (TGF-
β1), signaling pathways
, tissue repair, cytokines,
homeostasis.
Introduction:
The regulation of tissue repair and
regeneration is governed at multiple levels of biological
organization. These regulatory mechanisms ensure
tissue integrity and functional recovery in response to
injury or pathological conditions. The primary
regulatory systems include:
•
Intracellular and intercellular mechanisms
•
Hormonal and cytokine signaling
•
Neural regulation
•
Functional (compensatory) responses
•
Inter-organ coordination
Each of these systems plays a critical role in
orchestrating the complex processes of regeneration
and maintaining homeostasis following tissue damage.
Intracellular and Intercellular Regulation
. Intracellular
regeneration is a universal feature shared by all cells,
including neurons. Under normal physiological
conditions, cellular proliferation is restrained by
chalones
—
a class of glycoproteins that inhibit cell
division. When tissue injury occurs, antichalones are
produced to counteract chalones, thereby promoting
cell proliferation.
Additionally, degradation products released from
damaged cells can exert stimulatory effects on
neighboring undamaged cells, prompting them to enter
the mitotic cycle and contribute to tissue restoration.
Hormonal and Cytokine Mechanisms
. Experimental
studies have demonstrated that hormones secreted by
the pituitary gland, thyroid, adrenal cortex, gonads,
and pancreas influence reparative processes. Notably,
TGF-
β1 exhibits three principal biological effects:
1.
Inhibition of proliferation in most somatic and
immune cells
2.
Stimulation of growth in certain mesenchymal
cells
3.
Immunosuppressive
action,
particularly
enhancing the production of extracellular matrix
components
As such, TGF-
β1 is integral to tissue remodeling and
fibrosis, particularly in chronic inflammatory conditions
and wound healing.
Neural Mechanisms. The nervous system fulfills a
trophic role in regeneration through the release of
neurotrophic factors from nerve terminals. These
factors stimulate cell survival, differentiation, and
American Journal Of Social Sciences And Humanity Research
163
https://theusajournals.com/index.php/ajsshr
American Journal Of Social Sciences And Humanity Research (ISSN: 2771-2141)
proliferation, thereby contributing significantly to
tissue repair.
Functional (Compensatory) Mechanisms. In the
context of organ or tissue damage, the remaining viable
cells are subjected to increased physiological workload,
which results in elevated metabolic activity. This
metabolic shift triggers intracellular regenerative
processes and may also lead to cell proliferation or
hypertrophy, thereby compensating for functional loss.
Inter-Organ Coordination. Inter-organ regulatory
mechanisms involve the coordination of multiple organ
systems, facilitated through neuroendocrine pathways.
These include the hypothalamic-pituitary-adrenal axis
and autonomic signaling, which mobilize immune cells
and stem/progenitor cells to sites of tissue injury,
thereby enhancing regeneration.
Regeneration can be stimulated through a variety of
localized interventions, which include:
•
Physical stimuli: e.g., mechanical injury that
initiates a regenerative response;
•
Chemical agents: the application of specific
chemical compounds;
•
Biological materials: use of biological tissues to
promote regeneration;
•
Prosthetic methods: implementation of
temporary or permanent prostheses to facilitate
structural or functional restoration.
Additionally, a number of pharmacological agents and
nutritional strategies are employed to support
regenerative processes. For example, in experimental
settings, fetal serum has been shown to accelerate the
union of long bones. Hormones secreted by various
endocrine glands also contribute significantly to
reparative regeneration. Furthermore, diet has a
considerable impact on the dynamics and effectiveness
of the regenerative response.
Reparative Regeneration: Typology and Mechanisms
.
Reparative regeneration refers to the restoration of a
div part following its damage or loss. It is classified
into two primary types:
•
Typical reparative regeneration: the lost part is
replaced with an identical structure. This may result
from external injury (e.g., amputation) or through
autotomy
—
a deliberate shedding of a div part for
survival, such as a lizard detaching its tail.
•
Atypical
reparative
regeneration:
the
regenerated structure differs quantitatively or
qualitatively from the original tissue.
Regeneration Forms Based on Morphological
Outcomes
1.
Homomorphosis: the exact same organ or part
is restored at the site of the loss.
Example: A new limb develops in a newt following
amputation.
2.
Heteromorphosis: a different organ or
structure forms in place of the lost one.
Example: In crustaceans, an antenna may regenerate at
the site of an excised eye.
3.
Hypermorphosis: more than one structure
regenerates in place of a single lost organ.
Example: Two forelimbs may grow in a newt in place of
one removed.
4.
Regenerative hypertrophy: only the mass of an
organ is restored, not its form.
Example: After partial hepatectomy, the remaining
liver tissue increases in volume rather than
regenerating the exact removed segment.
5.
Compensatory hypertrophy: the remaining
organ of a paired system enlarges and assumes the
function of the lost one.
Example: Enlargement of one kidney after the removal
of the other.
6.
Somatic embryogenesis: a complete organism
develops from a fragment of the div.
Example: A hydra can regenerate entirely from one of
its ~200 div segments.
Types of Regeneration Based on Mechanism
1.
Epimorphosis:
the
missing
part
is
reconstructed via outgrowth from the wound site.
Example: Limb regeneration in salamanders.
2.
Morphallaxis: structural reorganization of the
remaining tissue forms a smaller but functionally
complete organ.
Example: Limb regeneration in cockroaches.
3.
Endomorphosis: enhanced cell proliferation
within the remaining part of an organ restores its
function.
Example: Regrowth of liver tissue in vertebrates.
Stem Cells in Regenerative Medicine
. Some experts in
regenerative medicine posit that regenerative function
can be reactivated through the use of stem cells. In
adults, stem cells are rare and are typically located in
the lower spine, near the dorsal root ganglia. These are
pluripotent cells that played a fundamental role in
embryogenesis. The first eight cells formed after
fertilization are classified as primordial stem cells,
which initiate embryonic development.
Researchers have proposed that stimulating these cells
may require activation of a specific vortex field (often
referred to in esoteric contexts as Merkaba), which
American Journal Of Social Sciences And Humanity Research
164
https://theusajournals.com/index.php/ajsshr
American Journal Of Social Sciences And Humanity Research (ISSN: 2771-2141)
could potentially induce stem cell proliferation and
systemic regeneration
—
an ideal yet speculative vision
in regenerative medicine.
Role of TGF-
β1 in Regeneration. Transforming Growth
Factor Beta 1 (TGF-
β1) is a multifunctional cytokine
that regulates:
1.
Inhibition of proliferation in most somatic cells;
2.
Stimulation of mesenchymal cell growth;
3.
Immunosuppressive
activity,
including
enhancement of extracellular matrix (ECM) synthesis.
Since the early 2000s, especially after 2005, TGF-
β1 has
been recognized as a key mediator in the immune
pathogenesis of hereditary connective tissue diseases
and other immune-related conditions.
The TGF-
β family was first described in 1978, with TGF
-
β1 being the first identified isoform, initially isolated
from platelets in the 1990s. The TGF-
β1 gene is located
on chromosome 19. The name reflects the protein’s
ability to induce phenotypic transformation in cultured
normal cells.
Cellular Sources and Activation of TGF-
β1
TGF-
β1 is produced by:
•
Monocytes
and
macrophages
(primary
sources);
•
Fibroblasts, endothelial cells, neutrophils,
eosinophils, mast cells, smooth muscle cells, and
various tumor cells.
It is synthesized as an inactive precursor
(prepropeptide). Following processing, a signal peptide
and prodomain are cleaved off, resulting in the mature
protein. However, the latency-associated peptide (LAP)
remains non-covalently bound to the mature TGF-
β1,
rendering it biologically inactive and stored in the
extracellular matrix.
Activation of TGF-
β1 occurs in response to tissue injury
and involves several mechanisms, including:
•
Proteolytic cleavage,
•
Integrin interactions,
•
pH shifts, and
•
Reactive oxygen species (ROS).
Once activated, TGF-
β1 initiates downstream signaling
cascades crucial to tissue remodeling, fibrosis, and
wound healing.
Three main types of TGF-
β receptors are distinguished:
Type I, II, and III receptors. Type I and II receptors are
transmembrane glycoproteins with molecular weights
of approximately 55 and 70 kDa, respectively. Due to its
dimeric structure, TGF-
β1 can simultaneously bind to
both type I and type II specific receptors, while type III
receptor facilitates this interaction by steric support.
The type I receptor possesses serine/threonine kinase
activity, which enables it to phosphorylate a group of
intracellular proteins known as Smads (Smad and mad-
related proteins). Upon TGF-
β1 binding, the type I and
type
II
receptor
complex
undergoes
trans-
American Journal Of Social Sciences And Humanity Research
165
https://theusajournals.com/index.php/ajsshr
American Journal Of Social Sciences And Humanity Research (ISSN: 2771-2141)
phosphorylation, activating the signaling cascade.
Once activated, type I receptors phosphorylate
receptor-regulated Smads (R-Smads), which then form
a complex with Smad4. This complex translocates into
the nucleus, where it regulates transcription of target
genes. Divergent inhibitory Smads (Smad6 and Smad7)
act as negative regulators of the TGF-
β1 signaling
pathway.
TGF-
β1 exhibits inhibitory effects on the proliferation
of T and B lymphocytes, as well as on the maturation
and activation of macrophages, thus playing a critical
role in immune homeostasis, particularly in
downregulating inflammatory responses. Additionally,
TGF-
β1 suppresses NK cell activity, inhibits cytotoxicity
of CD8+ T lymphocytes, as well as lymphokine-
activated killer cells, and reduces cytokine production
and secretion of certain immunoglobulins.
In lymphoid, epithelial, and endothelial cells, TGF-
β1
functions as a growth inhibitor. It is also involved in
nephron development, especially in the formation of
the glomerular capillary network.
Clinical
Implications
and
Diagnostic
Utility.
Measurement of TGF-
β1 levels in peripheral blood is
recommended in the diagnosis and monitoring of
various
conditions
associated
with
chronic
inflammation, including:
•
Alzhei
mer’s disease
•
Down syndrome
•
Acquired immunodeficiency syndrome (AIDS)
•
Parkinson’s disease
•
Bone marrow and skeletal disorders
•
Glomerulonephritis
•
Nephropathy
•
Diabetes mellitus
•
Glomerulosclerosis
•
Systemic lupus erythematosus
•
Autoimmune hepatitis
•
Chronic fatigue syndrome
•
Sepsis
•
Stroke
•
Various cancers (e.g., prostate, bladder, liver)
Elevated levels of TGF-
β1 have been detected in
chronic fatigue syndrome and in patients with Guillain
–
Barré
–
Strohl syndrome. In Kawasaki disease, an inverse
correlation between TGF-
β1 levels and disease activity
has been observed, particularly in patients with IgA
deficiency.
Increased serum TGF-
β1 levels in patients with
thrombocytopenic purpura suggest its involvement in
hematopoiesis. The cytokine also plays an essential role
in bone marrow metabolism, and its regulatory
function in osteoblast-osteoclast interactions is
currently under investigation.
Elevated TGF-
β1 expression has been reported in
prostate cancer, bladder cancer, and hepatocellular
carcinoma. In contrast, reduced serum levels of TGF-
β1
observed in sepsis and stroke may reflect alterations in
the patient’s immunoinflammatory status.
Furthermore, it is hypothesized that inhibition of TGF-
β1
si
gnaling
pathways
may
contribute
to
atherosclerotic changes in the vascular wall, by
enhancing inflammation and reducing collagen
synthesis, thereby weakening atheromatous plaques.
American Journal Of Social Sciences And Humanity Research
166
https://theusajournals.com/index.php/ajsshr
American Journal Of Social Sciences And Humanity Research (ISSN: 2771-2141)
It has been established that elevated levels of TGF-
β1
in patients represent one of the key prognostic markers
of pathological fibrosis. The activation of stromal
elements is considered a central mechanism in the
airway wall remodeling process. The number of stromal
mesenchymal cells increases proportionally with the
thickening and densification of the reticular collagen
layer.
In patients with ischemic heart disease, serum TGF-
β1
levels are significantly higher compared to healthy
individuals. Several authors suggest that a dysbalance
between pro-inflammatory and anti-inflammatory
cytokines, with a predominance of the latter, underlies
the development and maintenance of chronic
inflammation, which ultimately culminates in fibrosis.
REFERENCES
Iriskulov B.U., Kurbanov G.T. Role of the transforming
growth factor β in the path
ogenesis of structural
remodeling of the tracheal slice in experimental
tracheobronchitis. Natural Volatiles & Essential Oils,
2021; 8(5): 12116-12120.
https://nveo.org/index.php/journal/article/view/3477
/2855
Zubova S.G., et al. Synthesis and expression of
transforming growth factor beta by activated
macrophages. Questions of Oncology, 1996; 42(5): 80
–
85. (in Russian)
Bartram U., Christian P. Role of transforming growth
factor-alpha (TGF-
α) in neonatal lung disease. Chest,
2004; 125: 754
–
765.
Bakin A.V. p38 mitogen-activated protein kinase is
required
for
TGF-beta-mediated
fibroblastic
transdifferentiation and cell migration. Journal of Cell
Science, 2002; 115: 3193
–
3206.
Weber V.R., Gubskaya P.M., Bondarenko V.S. Structural
changes of the heart in experimental animals during
modeling of different versions of acute stress and
opportunities for medical correction. Vestnik of
Novgorod State University, Medical Sciences, 2011; 62:
39
–
43.
Huntgeburth M., Tiemann K., Shahverdyan R., et al.
Transfor
ming Growth Factor β1 oppositely regulates
the hypertrophic and contractile response to β
-
adrenergic stimulation in the heart. PLoS ONE, 2011; 6:
e26628. doi:10.1371/journal.pone.0026628.
American Journal Of Social Sciences And Humanity Research
167
https://theusajournals.com/index.php/ajsshr
American Journal Of Social Sciences And Humanity Research (ISSN: 2771-2141)
Ghosh A.K., Bradham W.S., Gleaves L.A., et al.
Involvement of constitutive transforming growth
factor
—
signaling and endothelial-to-mesenchymal
transition. Circulation, 2010; 122: 1200
–
1209.
Kurbanov G.T. Role of macrophages and cytokines in
the formation of inflammation and progression of
chronic obstructive pulmonary disease. Science and
Education Scientific Journal, 2023; 4(10): 66
–
72. ISSN
2181-0842.
Kurbanov G.T., Iriskulov B.U. Role of the transforming
growth factor β in the pathogenesis of st
ructural
remodeling of the tracheal slice in experimental
tracheobronchitis. American Journal of Medicine and
Medical Sciences, 2022; 12(2). DOI:10.5923/j.ajmms.
Trulev A.S., Kudryavtsev I.V., Nazarov P.G. Acute phase
inflammatory factors as modulators of mast cell and
fibroblast interactions. Bulletin of the West Siberian
Scientific Center of the Siberian Branch of the Russian
Academy of Medical Sciences, 2012; 3(85), Part 2. (in
Russian)
